Pelvic ultrasound results and breast stages for patient 5
| Cycle of Zoladex LA treatment | ||||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Age (years) | 5.1 | 6.3 | ||||||
| Breast stage | 2 | 2+ | 2+ | 2 | 2 | 2 | 2 | 2+ |
| Uterine shape | C | P | C | C | C | C | C | P |
| Uterine length (cm) | 3.0 | 4.7 | 4.6 | 3.0 | 2.4 | 3.6 | 3.0 | 3.5 |
| Endometrial echo (mm) | – | 2.6 | – | – | – | – | – | – |
| Right ovary volume (cm3) | 1.1 | 2.7 | 15.5 | 1.4 | 1.1 | 1.6 | 2.3 | 3.4 |
| Left ovary volume (cm3) | 1.8 | 1.3 | 3.8 | 2.6 | 2.0 | 2.0 | 1.6 | 1.0 |
Zoladex LA injections were given every 10 weeks for the first cycle only, then every nine weeks.
C, cylindrical (mid-childhood shape with cervix and fundus approximately the same); P, pear shaped (adult shape with fundus larger than cervix).